NT
NeuroVanda develops targeted therapies for neurodegenerative diseases by utilizing disease-relevant models and precise therapeutic modalities based on in-depth insights into disease mechanisms. This approach aims to improve treatment efficacy and patient outcomes in conditions such as Alzheimer's and Parkinson's disease.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- NeuroVanda develops targeted therapies for neurodegenerative diseases by utilizing disease-relevant models and precise therapeutic modalities based on in-depth insights into disease mechanisms. This approach aims to improve treatment efficacy and patient outcomes in conditions such as Alzheimer's and Parkinson's disease.